Valuation: Artivion, Inc.

Market Cap 1.09B 952M 879M 820M 1.54B 103B 1.58B 10.57B 4.08B 50.69B 4.08B 3.99B 176B P/E 2026 *
236x
P/E 2027 * 54.8x
Enterprise Value 1.09B 952M 879M 820M 1.54B 103B 1.58B 10.57B 4.08B 50.69B 4.08B 3.99B 176B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 2.01x
Free-Float
89.39%
Yield 2026 *
-
Yield 2027 * -
1 week+10.73%
Current month+2.62%
1 month+2.62%
3 months-35.74%
6 months-49.87%
Current year-49.81%
1 week 17.3
Extreme 17.3
21
1 month 17.2
Extreme 17.2
21
3 years 11.3
Extreme 11.3
40.95
5 years 10.1
Extreme 10.1
40.95
10 years 10.1
Extreme 10.1
40.95
Manager TitleAgeSince
Chief Executive Officer 59 02/09/2014
Director of Finance/CFO 53 04/12/2023
Chief Tech/Sci/R&D Officer 56 01/06/2023
Director TitleAgeSince
Director/Board Member 71 01/12/2003
Director/Board Member 66 01/12/2003
Director/Board Member 61 01/05/2012
Change 5-day change 1-year change 3-year change Capi.($)
+0.51%+6.01%-24.32%+29.80% 1.09B
-1.50%+5.56%-31.01%-13.89% 161B
-0.06%+2.09%-5.92%-6.73% 104B
-1.57%+3.82%-5.93%+47.83% 54.8B
+0.56%-2.02%+51.27%+51.98% 53.31B
-0.47%+10.29%-9.17%-40.43% 42.76B
+1.90%+14.12% - - 33.49B
-0.23%+1.32%-18.94%-45.30% 27B
+1.09%+7.57%+62.05%-6.01% 25.06B
-1.13%+6.41%-10.70%-3.51% 20.78B
Average -0.16%+5.30%+0.81%+1.53% 58.03B
Weighted average by Cap. -0.50%+4.65%-5.74%-1.41%

Financials

2026 *2027 *
Net sales 486M 426M 393M 367M 691M 45.99B 707M 4.73B 1.83B 22.69B 1.83B 1.79B 78.77B 540M 473M 436M 408M 767M 51.05B 785M 5.25B 2.03B 25.19B 2.03B 1.98B 87.44B
Net income 5.11M 4.47M 4.13M 3.85M 7.25M 483M 7.42M 49.66M 19.17M 238M 19.17M 18.75M 827M 22.61M 19.8M 18.28M 17.07M 32.13M 2.14B 32.86M 220M 84.91M 1.05B 84.92M 83.05M 3.66B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
-
Date Price Change
30/06/26 19.60 0.00%
29/06/26 €19.60 +1.03%
26/06/26 €19.40 -3.00%
25/06/26 €20.00 +3.63%
24/06/26 €19.30 +7.22%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
22.39USD
Average target price
42.00USD
Spread / Average Target
+87.58%

Quarterly revenue - Rate of surprise